收费全文 | 3232篇 |
免费 | 242篇 |
国内免费 | 22篇 |
耳鼻咽喉 | 12篇 |
儿科学 | 115篇 |
妇产科学 | 50篇 |
基础医学 | 371篇 |
口腔科学 | 122篇 |
临床医学 | 398篇 |
内科学 | 629篇 |
皮肤病学 | 21篇 |
神经病学 | 310篇 |
特种医学 | 215篇 |
外科学 | 378篇 |
综合类 | 66篇 |
一般理论 | 3篇 |
预防医学 | 344篇 |
眼科学 | 18篇 |
药学 | 277篇 |
中国医学 | 3篇 |
肿瘤学 | 164篇 |
2022年 | 26篇 |
2021年 | 41篇 |
2020年 | 20篇 |
2019年 | 53篇 |
2018年 | 68篇 |
2017年 | 41篇 |
2016年 | 56篇 |
2015年 | 74篇 |
2014年 | 102篇 |
2013年 | 102篇 |
2012年 | 146篇 |
2011年 | 144篇 |
2010年 | 103篇 |
2009年 | 92篇 |
2008年 | 141篇 |
2007年 | 123篇 |
2006年 | 99篇 |
2005年 | 127篇 |
2004年 | 118篇 |
2003年 | 118篇 |
2002年 | 124篇 |
2001年 | 102篇 |
2000年 | 96篇 |
1999年 | 78篇 |
1998年 | 71篇 |
1997年 | 61篇 |
1996年 | 63篇 |
1995年 | 59篇 |
1994年 | 43篇 |
1993年 | 45篇 |
1992年 | 70篇 |
1991年 | 66篇 |
1990年 | 48篇 |
1989年 | 61篇 |
1988年 | 64篇 |
1987年 | 44篇 |
1986年 | 31篇 |
1985年 | 51篇 |
1984年 | 36篇 |
1983年 | 35篇 |
1982年 | 38篇 |
1981年 | 27篇 |
1980年 | 37篇 |
1979年 | 31篇 |
1978年 | 43篇 |
1977年 | 27篇 |
1976年 | 25篇 |
1973年 | 23篇 |
1972年 | 17篇 |
1969年 | 21篇 |
Background/Purpose
Morgagni diaphragmatic hernia (MH) is rare. We report our experience based on routine patch use in MH repair to curb recurrence. A systematic review and meta-analysis were performed to study the recurrence and complications associated with minimally invasive surgery and the use of patch.Methods
We retrospectively reviewed all cases of MH who underwent first-time repair in 2012-2017 in our institution to determine recurrence and complication rate. A MEDLINE search related to minimally invasive surgery (MIS) and patch repair of MH was conducted for systematic review. Eligible articles published from 1997-2017 with follow-up data available were included. Primary outcomes measured were recurrence and complication. Meta-analysis to compare open versus MIS and primary versus patch repair in the MIS group were performed in comparative cohorts. Continuous data were presented as median (range), and statistical significance was P < 0.05.Results
In our institution, 12 consecutive patients aged 17-month-old (22 days-7 years), underwent laparoscopic patch repair of MH, with one conversion to laparotomy. No recurrence or significant complication occurred over a follow-up period of 8 months (1-48 months).Thirty-six articles were included from literature review and were combined with the current series. All were retrospective case reports or series, of which 6 were comparative cohorts with both MIS and open repairs. A total of 296 patients from 37 series were ultimately used for analysis: 80 had open repair (4 patch) and 216 had MIS repair (32 patch), with a patch rate of 12%. There were 13 recurrences (4%): no difference between open and MIS repairs (4/80 vs 9/216, p = 0.75); recurrence rate following primary repair was 13/260 (5%), but no recurrence occurred with 36 patch repairs. Meta-analysis showed no difference in recurrence between open and MIS repair (p = 0.83), whereas patch repair was associated with 14% less recurrence compared with primary repair, although it did not reach statistical significance (p = 0.12). There were 13 complications (5%): no difference between open and MIS repairs (5/80 vs 8/216, p = 0.35). One small bowel obstruction occurred in a patient who had laparoscopic patch repair.Conclusion
In MH, recurrence and complication rates are comparable between MIS and open repairs. Use of patch appeared to confer additional benefit in reducing recurrence.Type of Study
Systematic reviewLevel of Evidence
3A 相似文献Background
Low incidence of breast cancer in men (BCM) (<?1% of all breast cancers) has led to a paucity of outcome data. This study evaluated the impact of age on BCM outcomes.Methods
For this study, BCM patients treated between 2000 and 2011 were stratified by age (≤?65 or?>?65 years). Kaplan–Meier methods were used to compare overall survival (OS) and breast cancer-specific survival (BCSS). Competing-risk methods analyzed time to second primary cancers (SPCs), with any-cause death treated as a competing risk.Results
The study identified 152 BCM patients with a median age of 64 years (range 19–96 years). The median body mass index (BMI) was 28 kg/m2. Men age 65 years or younger (n?=?78, 51%) were more overweight/obese than men older than 65 years (n?=?74, 49%) (89% vs 74%, respectively; P?=?0.008). Both groups had similar nodal metastases rates (P?=?0.4), estrogen receptor positivity (P?=?1), and human epidermal growth factor receptor 2 (HER2)neu overexpression (P?=?0.6). Men 65 years of age or younger were more likely to receive chemotherapy (P?=?0.002). The median follow-up period was 5.8 years (range 0.1–14.4 years). The 5-year OS was 86% (95% confidence interval [CI] 80–93%), whereas the 5-year BCSS was 95% (95% CI 91–99%). The BCM patients 65 years of age and younger had better OS (P?=?0.003) but not BCSS (P?=?0.8). The 5-year cumulative incidence of SPC was 8.4% (95% CI 3.4–13.4%). The prior SPC rate was higher for men older than 65 years (n?=?20, 31%) than for those age 65 years or younger (n?=?7, 11%) (P?=?0.008). This did not account for differences in life years at risk. No difference was observed in SPC cumulative incidence stratified by age (P?=?0.3).Conclusions
Men 65 years of age or younger received more chemotherapy and had improved OS, but not BCSS, compared with men older than 65 years. For all BCM, SPC is a risk, and appropriate screening may be warranted.Concurrent with the UNAIDS 90-90-90 and NHAS plans, the District of Columbia (DC) launched its 90/90/90/50 plan (Plan) in 2015. The Plan proposes that by 2020, 90% of all DC residents will know their HIV status; 90% of residents living with HIV will be in sustained treatment; 90% of those in treatment will reach “Viral Suppression” and DC will achieve 50% reduction of new HIV cases. To achieve these goals targeted prevention strategies are imperative for areas where the relative risk (RR) of not being linked to care (NL), not retained in any care (NRC) and low viral suppression (NVSP) are highest in the District. These outcomes are denoted in this study as poor outcomes of HIV care continuum. This study applies the Bayesian model for RR for area specific random effects to identify the census tracts with poor HIV care continuum outcomes for DC.
MethodsThis analysis was conducted using cases diagnosed from 2010 to 2015 and reported to the surveillance system from the District of Columbia Department of Health (DC DOH), HIV/AIDS, Hepatitis, STD and TB Administration. The jurisdictions of the District of Columbia is divided into 179 census tracts. It is challenging to plot sparse data in ‘small’ local administrative areas, characteristically which may have a single-count datum for each geographic area. Bayesian methods overcome this problem by assimilating prior information to the underlying RR, making the predicted RR estimates robust.
ResultsThe RR of NL is higher in 59 (33%) out of 179 census tracts in DC. The RR of NRC was high in 46 (26%) of the census tracts while 52 census tracts (29%) show a high risk of having NVSP among its residents. This study also identifies clear correlated heterogeneity or clustering is evident in the northern tracts of the district.
ConclusionThe study finds census tracts with higher RR of poor linkage to care outcomes in the District. These results will inform the Plan which aims to increase targeted testing leading to early initiation of antiretroviral therapy. The uniqueness of this study lies in its translational scope where surveillance data can be used to inform local public health programs and enhance the quality of health for the people with HIV.
相似文献